Skip to content

Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa

Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorder in Female Adolescents With Anorexia Nervosa: a Randomized, Controlled Superiority Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04107870
Acronym
ANO-TERV
Enrollment
40
Registered
2019-09-27
Start date
2021-06-20
Completion date
2028-09-20
Last updated
2023-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa

Keywords

ANOREXIA NERVOSA, FEMALE ADOLESCENTS, BODY DYSMORPHIC DISORDER, VIRTUAL REALITY EXPOSURE THERAPY

Brief summary

Anorexia nervosa is defined in DSM V as a quantitative and qualitative dietary restriction resulting in significant weight loss, intense fear of weight gain, altered weight and body shape perception (body dysmorphic disorder) and low self-esteem influenced by weight or body shape. Body dysmorphic disorder is the most difficult symptom to manage in anorexia nervosa and its persistence is a factor associated with relapse. Virtual reality exposure therapy has proven its effectiveness in the management of post-traumatic stress disorder in the military and is a widely used therapy. The effectiveness of this treatment using new technologies has not yet been studied for the treatment of body dysmorphic disorder in anorexia nervosa and is not used routinely. It could represent an interesting alternative to the physical approach in psychomotor therapy, traditionally offered to patients suffering from anorexia nervosa. It is important to evaluate the effectiveness of virtual reality exposure therapy in the management of body dysmorphic disorder in patients with anorexia nervosa by comparing these two care techniques.

Detailed description

The aim of this study is to evaluate the effectiveness of Virtual Reality Exposure Therapy in the management of body dysmorphic disorder in patients with anorexia nervosa, compared to the traditionally proposed body approach in psychomotor therapy.

Interventions

BEHAVIORALVirtual Reality Exposure Therapy sessions

Female adolescents aged 13 to 18 are proposed virtual reality exposure therapy sessions, accompanied by a cognitive and behavioral therapy (CBT) therapist, to work on their body representations

BEHAVIORALPsychomotor therapy sessions

Psychomotor therapy sessions are proposed to female adolescents aged 13 to 18 years, ac-companied by a psychomotor therapist, to work on their body representations.

Sponsors

CHU de Reims
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

: * Female adolescents aged 13 to 18 * with a diagnosis of anorexia nervosa of all types (including purgative and hyperphagic) according to the DSM-V * French as first language * agreed to participate in the study * parental authority holders accepting her participation in the study * affiliated to a social security system Patients will not be included in the study: * with a somatic severity criterion: * Total aphagia * Body mass index (BMI) \< 14kg/m² for those over 17 years of age, BMI \< 13.2kg/m² for those aged 15-16 and BMI \< 12.7kg/m² for those aged 13-14. * Confusion * Bradycardia \<40/min, Tachycardia * Blood pressure \< 80/50mmHg * Hypothermia \<35.5°C * Severe metabolic disorders: hypokalemia \< 2.5 mmol/l, hyponatremia \< 125mmol/l or hypernatremia \> 150 mmol/l, hypophosphoremia \< 0.5 mmol/l * Acetonuria, hypoglycemia \< 0.6g/l * Creatinine elevation \> 100micromol/l * Cytolysis \> 4N * Leuconeutropenia \<1000/mm3 * Thrombocytopenia \<6000000/mm3 * Suicide attempt in the last month before inclusion * Receiving benzodiazepine treatment outside the prescription limits. * Psychotic patients or patients with psychoactive substance addiction according to MINI KID criteria (Sheehan DV et al. Reliability and validity of the Mini International Neuropsychiatric Interview for children and adolescents (MINI Kid). J Clin Psychiatry 2010;71(3):313-326).

Design outcomes

Primary

MeasureTime frameDescription
Body Shape Questionnaire12 monthsThe Body Shape Questionnaire (BSQ) measures concerns about body shape. The BSQ can be divided into 4 sub scores: avoidance and social shame of body exposure, body dissatisfaction with lower body parts, use of laxatives and vomiting to reduce body dissatisfaction and inappropriate cognitions and behaviours to control weight.

Secondary

MeasureTime frameDescription
Eating Disorder Inventory12 monthsEating Disorder Inventory (EDI-2) is a self questionnaire to assess the severity of symptoms of eating disorders and to evaluate their changes

Countries

France

Contacts

Primary ContactJulien EUTROPE
jeutrope@chu-reims.fr03 26 78 39 56

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026